# The South Proxa-Rescue AndroCoV Trial Against COVID-19

> **NCT05126628** · PHASE3 · COMPLETED · sponsor: **Corpometria Institute** · enrollment: 133 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Proxalutamide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05126628
- **Lead sponsor:** Corpometria Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-06
- **Primary completion:** 2021-03-16
- **Final completion:** 2021-04-15
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2021-11-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05126628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05126628, "The South Proxa-Rescue AndroCoV Trial Against COVID-19". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05126628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*